6 research outputs found
LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle
No full textSoluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manner to the Full-Length LRIG2
No full textEnantiomeric resolution and chiral recognition of racemic nicotine and nicotine analogs by .beta.-cyclodextrin complexation. Structure-enantiomeric resolution relationships in host-guest interactions
No full textHigh-performance liquid chromatography using β-cyclodextrin bonded phases was examined for the enantiomeric separation of racemic nicotine and 19 racemic nicotine analogues. Ten pairs of enantiomers were separated by this technique. This represents the first reported facile and direct separation of these racemates. Effects of pH, mobile phase composition, and structural features of the substrates (i.e., position and size of substituents, presence of pyrrolidine ring or hydrogen bonding functionalities, basicity) on the enantioselectivity are examined. Various structural aspects of the compounds were related to retention to the cyclodextrln-modlfied support and to the enantiomeric separations observed. Implications of this work to host-guest complexation are discussed. © 1988, American Chemical Society. All rights reserved
LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes
No full text
